glp-1 medication fatigue management strategies Weight maintenance after discontinuation of therapies The GLP-1 Slump: Your Guide

Structured Tapering Patients transitioning off higher GLP-1 doses may benefit from gradual reduction rather than abrupt discontinuation

Two months later, visual acuity had improved to 20/20 in both eyes with significant improvement in papilledema and a reduction in the size of the blind spots

These drugs are both dopamine and cholinergic receptor antagonists that act on the area postrema in the brainstem

The reduced blood flow can cause sudden vision loss, which usually occurs without warning and is painless

It is not approved for human or veterinary applications and must not be used for diagnostic or therapeutic purposes

Brancaccio: Can Lily or Novo, the big pharmas, can they meet demand